NCT04129151 2024-08-01Palbociclib + Ganitumab In Ewing SarcomaDana-Farber Cancer InstitutePhase 2 Terminated10 enrolled 15 charts
NCT00038142 2020-01-29Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma PatientsM.D. Anderson Cancer CenterPhase 2 Terminated46 enrolled 5 charts
NCT00617890 2018-08-23A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)Merck Sharp & Dohme LLCPhase 2 Terminated219 enrolled 13 charts
NCT01313884 2017-11-24Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings SarcomaStanford UniversityPhase 2 Terminated3 enrolled 7 charts
NCT00568464 2009-07-07Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)Fudan UniversityPhase 2 Terminated10 enrolled